title: Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.
authors.affiliation: Department of Medicine, Division of Medical Oncology, Stanford University Medical Center, Stanford, California 94305, USA. radvani@stanford.edu
authors.forename: Ranjana H
authors.initials: RH
authors.lastname: Advani
authors.forename: Richard T
authors.initials: RT
authors.lastname: Hoppe
authors.forename: Lauren S
authors.initials: LS
authors.lastname: Maeda
authors.forename: David M
authors.initials: DM
authors.lastname: Baer
authors.forename: Joseph
authors.initials: J
authors.lastname: Mason
authors.forename: Saul A
authors.initials: SA
authors.lastname: Rosenberg
authors.forename: Sandra J
authors.initials: SJ
authors.lastname: Horning